ZAG Antibodies

Santa Cruz Biotechnology features a diverse variety of ZAG monoclonal antibodies for advanced research in molecular biology. Zinc-alpha2-glycoprotein (ZAG) monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Zinc-alpha2-glycoprotein (ZAG) is a multifunctional protein that plays a significant role in lipid metabolism and has been implicated in cancer progression and cachexia. Research has shown that Zinc-alpha2-glycoprotein (ZAG) modulates immune responses and influences cell proliferation, making it an important target for therapeutic interventions. Understanding Zinc-alpha2-glycoprotein (ZAG) is crucial for developing strategies to combat various diseases, including obesity and cancer. Zinc-alpha2-glycoprotein (ZAG) research continues to reveal new insights into cellular processes and disease mechanisms. Ongoing studies of Zinc-alpha2-glycoprotein (ZAG) contribute to our understanding of metabolic disorders and cancer biology. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge and potentially develop new therapeutic strategies.